GB9417366A
GB9417366D0
(en)
|
1994-08-26 |
1994-08-26 |
Cell cycle regulated repressor and DNA element
|
GBGB9506466.3A
GB9506466D0
(en)
|
1994-08-26 |
1995-03-29 |
Cell cycle regulated repressor and dna element
|
PCT/GB1995/002000
WO1996006943A1
(en)
|
1994-08-26 |
1995-08-23 |
Cell cycle regulated repressor and dna element
|
PT95929181T
PT802985E
(en)
|
1994-08-26 |
1995-08-23 |
REPRESSOR REGULATED BY CELL CYCLE AND DNA ELEMENT
|
IL11505195A
IL115051A0
(en)
|
1994-08-26 |
1995-08-23 |
Cell cycle regulated repressor and dna element
|
ZA9507074A
ZA957074B
(en)
|
1994-08-26 |
1995-08-23 |
Cell cycle regulated repressor and DNA element.
|
CA002198080A
CA2198080A1
(en)
|
1994-08-26 |
1995-08-23 |
Cell cycle regulated repressor and dna element
|
US08/793,660
US6214614B1
(en)
|
1994-08-26 |
1995-08-23 |
Cell cycle regulated repressor and DNA element
|
DE69529174T
DE69529174T2
(en)
|
1994-08-26 |
1995-08-23 |
CELL CYCLE REGULATED REPRESSOR AND DNA ELEMENT
|
ES95929181T
ES2190787T3
(en)
|
1994-08-26 |
1995-08-23 |
REPRESSOR REGULATED BY THE CELL CYCLE AND DNA ELEMENT.
|
DK95929181T
DK0802985T3
(en)
|
1994-08-26 |
1995-08-23 |
Cell cycle regulated repressor and DNA element
|
AU32639/95A
AU711012B2
(en)
|
1994-08-26 |
1995-08-23 |
Cell cycle regulated repressor and DNA element
|
AT95929181T
ATE229569T1
(en)
|
1994-08-26 |
1995-08-23 |
CELL CYCLE REGULATED REPRESSOR AND DNA ELEMENT
|
EP95929181A
EP0802985B1
(en)
|
1994-08-26 |
1995-08-23 |
Cell cycle regulated repressor and dna element
|
NZ29149595A
NZ291495A
(en)
|
1994-08-26 |
1995-08-23 |
Cell cycle regulated repressor and DNA element
|
JP8508548A
JPH10508188A
(en)
|
1994-08-26 |
1995-08-23 |
Cell cycle regulatory repressor and DNA element
|
EP95931205A
EP0807183B1
(en)
|
1994-08-26 |
1995-08-25 |
Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
|
DK95930524T
DK0777739T3
(en)
|
1994-08-26 |
1995-08-25 |
Gene therapeutic treatment of vascular disease with a cell-specific cell cycle-dependent active substance
|
ES95930524T
ES2146770T3
(en)
|
1994-08-26 |
1995-08-25 |
TREATMENT OF GENE THERAPY OF VASCULAR DISEASES THROUGH AN ACTIVE CYTO-SPECIFIC SUBSTANCE AND DEPENDENT ON THE CELL CYCLE.
|
US08/793,107
US5830880A
(en)
|
1994-08-26 |
1995-08-25 |
Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound
|
EP95931933A
EP0777740B1
(en)
|
1994-08-26 |
1995-08-25 |
Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
|
CA002198462A
CA2198462A1
(en)
|
1994-08-26 |
1995-08-25 |
Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
|
DE59509100T
DE59509100D1
(en)
|
1994-08-26 |
1995-08-25 |
GENTHERAPEUTIC TREATMENT OF TUMORS WITH AN ENDOTHEL CELL-SPECIFIC, CELL CYCLE-DEPENDENT ACTIVE SUBSTANCE
|
CN95195134A
CN1158144A
(en)
|
1994-08-26 |
1995-08-25 |
Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle
|
AU33874/95A
AU690733B2
(en)
|
1994-08-26 |
1995-08-25 |
Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle
|
PT95931204T
PT804601E
(en)
|
1994-08-26 |
1995-08-25 |
TREATMENT OF TUMORS FOR GENETIC THERAPY WITH A SPECIFIC ACTIVE INGREDIENT OF ENDOTHELIAL CELLS DEPENDING ON THE CELL CYCLE
|
DK95931933T
DK0777740T3
(en)
|
1994-08-26 |
1995-08-25 |
Gene Therapeutic Treatment of Central Nervous System Disorders (CNS) with a Cell-Specific Cell Cycle-Dependent Active Stomach
|
JP8508478A
JPH10505234A
(en)
|
1994-08-26 |
1995-08-25 |
Gene therapy of diseases of the central nervous system using cell-specific active compounds that are cell cycle dependent
|
AU34732/95A
AU696593B2
(en)
|
1994-08-26 |
1995-08-25 |
Gene therapy of tumours with an endothelial cell-specific, cell cycle-dependent active compound
|
AT95931205T
ATE198492T1
(en)
|
1994-08-26 |
1995-08-25 |
GENE THERAPY OF DISEASES CAUSED BY THE IMMUNE SYSTEM USING A CELL-SPECIFIC CELL CYCLE-REGULATED ACTIVE SUBSTANCE
|
JP8508479A
JPH10506526A
(en)
|
1994-08-26 |
1995-08-25 |
Gene Therapy for Tumors Using Active Compounds Dependent on Endothelial Cells-Specific Cell Cycle
|
DE59508945T
DE59508945D1
(en)
|
1994-08-26 |
1995-08-25 |
GENE THERAPY OF DISEASES CONDITIONED BY THE IMMUNE SYSTEM WITH THE AID OF A CELL-SPECIFIC CELL-CYCLE-REGULATED ACTIVE SUBSTANCE
|
DE59508145T
DE59508145D1
(en)
|
1994-08-26 |
1995-08-25 |
GENTHERAPEUTIC TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM (CNS) BY A CELL-SPECIFIC, CELL CYCLE-DEPENDENT ACTIVE SUBSTANCE
|
EP95931204A
EP0804601B1
(en)
|
1994-08-26 |
1995-08-25 |
Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle
|
JP50848096A
JP2002502228A
(en)
|
1994-08-26 |
1995-08-25 |
Gene therapy of diseases related to the immune system using active compounds specific to cells controlled by the cell cycle
|
AU34733/95A
AU690336B2
(en)
|
1994-08-26 |
1995-08-25 |
Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
|
PCT/EP1995/003369
WO1996006939A1
(en)
|
1994-08-26 |
1995-08-25 |
Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
|
PCT/EP1995/003370
WO1996006940A1
(en)
|
1994-08-26 |
1995-08-25 |
Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle
|
AT95931933T
ATE191507T1
(en)
|
1994-08-26 |
1995-08-25 |
GENETHERAPEUTIC TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM (CNS) USING A CELL-SPECIFIC, CELL CYCLE-DEPENDENT ACTIVE SUBSTANCE
|
US08/793,109
US6384202B1
(en)
|
1994-08-26 |
1995-08-25 |
Cell-specific active compounds regulated by the cell cycle
|
CA002198472A
CA2198472A1
(en)
|
1994-08-26 |
1995-08-25 |
Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle
|
EP95930524A
EP0777739B1
(en)
|
1994-08-26 |
1995-08-25 |
Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle
|
CA002198474A
CA2198474A1
(en)
|
1994-08-26 |
1995-08-25 |
Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
|
AT95930524T
ATE191506T1
(en)
|
1994-08-26 |
1995-08-25 |
GENETHERAPEUTIC TREATMENT OF VASCULAR DISEASES USING A CELL-SPECIFIC, CELL CYCLE-DEPENDENT ACTIVE SUBSTANCE
|
ES95931933T
ES2146775T3
(en)
|
1994-08-26 |
1995-08-25 |
TREATMENT OF GENE THERAPY OF DISEASES OF THE CENTRAL NERVOUS SYSTEM (CNS) THROUGH A SPECIFIC ACTIVE INGREDIENT OF THE CELLS AND INDEPENDENT OF THE CELL CYCLE.
|
DK95931205T
DK0807183T3
(en)
|
1994-08-26 |
1995-08-25 |
Gene therapy of diseases caused by the immune system by a cell-specific active substance regulated by cellec
|
ES95931205T
ES2153045T3
(en)
|
1994-08-26 |
1995-08-25 |
GENE THERAPY OF DISEASES CONDITIONED BY THE IMMUNE SYSTEM, WITH HELP OF A SPECIFIC ACTIVE ACTIVE SUBSTANCE OF THE CELL AND REGULATED BY THE CELL CYCLE.
|
PT95931933T
PT777740E
(en)
|
1994-08-26 |
1995-08-25 |
TREATMENT FOR GENETIC THERAPY OF DISEASES OF THE CENTRAL NERVOUS SYSTEM (CNS) THROUGH A SPECIFIC ACTIVE SUBSTANCE OF CELL CYCLE DEPENDENT CELLS
|
AT95931204T
ATE199741T1
(en)
|
1994-08-26 |
1995-08-25 |
GENE THERAPEUTICAL TREATMENT OF TUMORS WITH AN ENDOTHELIAL CELL-SPECIFIC, CELL CYCLE-DEPENDENT ACTIVE SUBSTANCE
|
DK95931204T
DK0804601T3
(en)
|
1994-08-26 |
1995-08-25 |
Gene therapeutic treatment of tumors with an endothelial cell-specific active substance that is cell cycle dependent
|
PT95931205T
PT807183E
(en)
|
1994-08-26 |
1995-08-25 |
GENETIC THERAPY OF DISEASES INDUCED BY THE IMMUNE SYSTEM WITH THE ASSISTANCE OF A REGULATORY SUBSTANCE OF THE CELL SPECIFIC CELL CYCLE
|
RU97104482/14A
RU2197992C2
(en)
|
1994-08-26 |
1995-08-25 |
Method for applying genetic therapy of vascular diseases by means of active substance specific to cell and dependant on cellular cycle
|
PT95930524T
PT777739E
(en)
|
1994-08-26 |
1995-08-25 |
TREATMENT OF DISEASES OF VASES THROUGH GENETIC THERAPY THROUGH A SPECIFIC ACTIVE MATERIAL OF CELLS AND CELL CYCLE DEPENDENT
|
ES95931204T
ES2155137T3
(en)
|
1994-08-26 |
1995-08-25 |
TREATMENT FOR GENETIC TUMOR THERAPY WITH A SPECIFIC ACTIVE ACTIVE SUBSTANCE OF ENDOTELIAL CELLS AND DEPENDENT ON THE CELL CYCLE.
|
PCT/EP1995/003371
WO1996006941A1
(en)
|
1994-08-26 |
1995-08-25 |
Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
|
PCT/EP1995/003368
WO1996006938A1
(en)
|
1994-08-26 |
1995-08-25 |
Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle
|
KR1019970701226A
KR970705638A
(en)
|
1994-08-26 |
1995-08-25 |
Genetic therapies for tumors using endothelial cell-specific, cell cycle-dependent active compounds (Genetic therapy of tumors with an endothelial cell-specific active substance,
|
US08/793,110
US6358732B1
(en)
|
1994-08-26 |
1995-08-25 |
DNA for expression under control of a cell cycle-dependent promoter
|
DE59508144T
DE59508144D1
(en)
|
1994-08-26 |
1995-08-25 |
GENTHERAPEUTIC TREATMENT OF VASCULAR DISEASES BY A CELL-SPECIFIC, CELL-CYCLE-DEPENDENT ACTIVE SUBSTANCE
|
JP8508477A
JPH10507626A
(en)
|
1994-08-26 |
1995-08-25 |
Gene Therapy for Vascular Disease Using Cell-Specific Active Compounds That Change with the Cell Cycle
|
CA002198473A
CA2198473A1
(en)
|
1994-08-26 |
1995-08-25 |
Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound
|
AU35185/95A
AU695458B2
(en)
|
1994-08-26 |
1995-08-25 |
Genetic therapeutic treatment of diseases of the central nervous system (CNS) with a cell-specific active compound which is dependent on the cell cycle
|
FI970674A
FI113787B
(en)
|
1994-08-26 |
1997-02-18 |
Vector for expression of gene product in the cell
|
FI970768A
FI970768A
(en)
|
1994-08-26 |
1997-02-24 |
Gene therapeutic treatment of tumors with an endothelial cell-specific active substance dependent on the cell cycle
|
GR20000401227T
GR3033535T3
(en)
|
1994-08-26 |
2000-05-31 |
Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle
|
GR20000401226T
GR3033534T3
(en)
|
1994-08-26 |
2000-05-31 |
Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
|
GR20010400149T
GR3035322T3
(en)
|
1994-08-26 |
2001-01-31 |
Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
|
GR20010400847T
GR3035994T3
(en)
|
1994-08-26 |
2001-06-06 |
Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle
|
US10/112,953
US20030018005A1
(en)
|
1994-08-26 |
2002-04-02 |
Gene therapy of diseases associated with the immune system, using a cell-specific active compound which is regulated by the cell cycle
|